Check Size
$100K – $5M
Stage
Series A
AUM
$3.3B
Founded
1999
About Versant Ventures
Versant Ventures is a venture capital firm based in San Francisco, CA founded in 1999. Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe. The firm focuses on Series A investments across sectors including Biotech. The firm manages $3.3B in assets under management. Notable portfolio companies include Forty Seven, Stemcentrx, FibroGen, Dermira, Portola Pharmaceuticals and NextCure. Creates biotechnology companies from in-house discovery labs using big pharma discipline and scientific rigor.
Investment Thesis
“Creates biotechnology companies from in-house discovery labs using big pharma discipline and scientific rigor.”
Sector Focus
Biotech
Investment Stage
Pre-Seed
Seed
Series A
Series B+
Notable Portfolio Companies
Forty Seven
Stemcentrx
FibroGen
Dermira
Portola Pharmaceuticals
NextCure
